Key result
Cardiac insulin resistance fails to predict all-cause mortality in ischemic heart failure.
Why the study?
The impact of cardiac insulin resistance on overall survival and morbidity in patients with ischemic heart failure was still debated.
Cohort (n=131)
No
Answers are grounded in this paper and cite their sources.
Does not support using myocardial glucose uptake for prognosis in ischemic HF; hypothesis-generating for its distinction from diabetes and coronary flow reserve.
BACKGROUND & AIMS: The connection between peripheral insulin resistance (IR) and coronary artery disease is well-established. Both are major risk factors for the development of ischemic cardiomyopathy potentially leading to heart failure (HF). Whether cardiac IR also impacts overall survival and morbidity is still debated. We therefore aimed to test if cardiac IR predicts mortality and major cardiovascular events (MACE) in patients with HF scheduled for cardiac viability testing before revascularization. METHODS: F-Fluorodeoxyglucose (metabolism) positron emission tomography combined with computed tomography prior to a potential revascularization procedure. Cardiac IR was assessed by myocardial glucose uptake (MGU) in a remote (non-scarred) area of the left ventricle during a hyperinsulinemic-euglycemic clamp (1mIE/kg/min). RESULTS: MGU correlated with skeletal muscle glucose uptake (p < 0.001) and whole-body glucose uptake (M-value) (p < 0.001), whereas no association was observed for individuals with diabetes. MGU did not predict the risk of death or MACE. However, both overt diabetes and reduced coronary flow reserve predicted overall survival. CONCLUSION: Even though diabetes and related small-vessel disease is associated with increased mortality, cardiac IR per se does not predict cardiovascular morbidity and mortality.
No takes yet. Share an insight, caveat, or question.
Luong et al. (2021) conducted a cohort in Ischemic heart failure (n=131). Cardiac insulin resistance (myocardial glucose uptake) vs. Lower myocardial glucose uptake (below median) was evaluated on All-cause mortality (HR 1.0, 95% CI 0.97-1.0, p=0.58). Cardiac insulin resistance, assessed by myocardial glucose uptake, did not predict all-cause mortality in patients with ischemic heart failure, whereas overt diabetes and reduced coronary flow reserve did.
Synapse has enriched 10 related papers. Consider them for comparative context: